(Total Views: 609)
Posted On: 09/14/2019 7:01:33 AM
Post# of 154867
One more observation from what Dr Patterson said about check point inhibitors .
.Keytruda and Optiva he gave as an example .
At 200,000.00 a year per person they stop working about 3-6 months later , because many new cells which controlling tumors coming with their CCR5 .
Leronlimab might control that !!!!!
I remember Dr NP said long time ago that they thinking of doing study with Keytruda .., now with Dr Patterson observation hopefully it will be done soon .
First Letonlimab most probably could control all those often very severe autoimmune side effects of check point inhibitors , and now we know that it could control developing of resistance to them ...
Anytime we listen to any talks about Leronlimab we learning some new very exciting things !!!!
.Keytruda and Optiva he gave as an example .
At 200,000.00 a year per person they stop working about 3-6 months later , because many new cells which controlling tumors coming with their CCR5 .
Leronlimab might control that !!!!!
I remember Dr NP said long time ago that they thinking of doing study with Keytruda .., now with Dr Patterson observation hopefully it will be done soon .
First Letonlimab most probably could control all those often very severe autoimmune side effects of check point inhibitors , and now we know that it could control developing of resistance to them ...
Anytime we listen to any talks about Leronlimab we learning some new very exciting things !!!!
(1)
(0)
